Search

Solution structure of a TrkAIg2 domain construct for use in drug discovery
Authors
Shoemark, D.K., Fahey, M., Williams, C., Sessions, R.B., Crump, M.P., Allen-birt, S.J., A, S.
Assembly
Solution structure of a TrkAIg2 domain construct for use in drug discovery
Entity
1. Solution structure of a TrkAIg2 domain construct for use in drug discovery (polymer, Thiol state: all disulfide bound), 107 monomers, 11784.00 Da Detail

DDDDDVSFCA SVQLHTAVEM HHWCIPFSVD GQPAPSLRWL FNGSVLNETS FIFTEFLEPA ANETVRHGCL RLNQPTHVNN GNYTLLAANP CGQASASIMA AFMDNPF


Formula weight
11784.0 Da
Entity Connection
disulfide 2 Detail

IDTypeValue orderAtom ID 1Atom ID 2
1disulfidesing1:CYS9:SG1:CYS91:SG
2disulfidesing1:CYS24:SG1:CYS69:SG

Source organism
Homo sapiens
Exptl. method
solution NMR
Refine. method
ARIA 2.3
Data set
assigned_chemical_shifts
Chem. Shift Complete
Sequence coverage: 95.3 %, Completeness: 92.6 %, Completeness (bb): 94.7 % Detail

Polymer type: polypeptide(L)

Total1H13C15N
All92.6 % (1108 of 1196)93.4 % (570 of 610)90.9 % (428 of 471)95.7 % (110 of 115)
Backbone94.7 % (595 of 628)94.3 % (200 of 212)94.9 % (300 of 316)95.0 % (95 of 100)
Sidechain91.0 % (610 of 670)93.0 % (370 of 398)87.5 % (225 of 257)100.0 % (15 of 15)
Aromatic80.3 % (106 of 132)89.4 % (59 of 66)70.3 % (45 of 64)100.0 % (2 of 2)
Methyl98.2 % (108 of 110)100.0 % (55 of 55)96.4 % (53 of 55)

1. HIGH AFFINITY NERVE GROWTH FACTOR RECEPTOR

DDDDDVSFCA SVQLHTAVEM HHWCIPFSVD GQPAPSLRWL FNGSVLNETS FIFTEFLEPA ANETVRHGCL RLNQPTHVNN GNYTLLAANP CGQASASIMA AFMDNPF

Sample

Solvent system 90% H2O, 10% D2O, Pressure 1.000 atm, Temperature 293.000 K, pH 6.900, Details 0.5-1mM


#NameIsotope labelingTypeConcentration
1HIGH AFFINITY NERVE GROWTH FACTOR RECEPTOR[U-13C; U-15N]0.75 (±0.25) mM

LACS Plot; CA
Referencing offset: -0.06 ppm, Outliers: 1 Detail
LACS Plot; CB
Referencing offset: -0.06 ppm, Outliers: 1 Detail
LACS Plot; HA
Referencing offset: -0.08 ppm, Outliers: 2 Detail
LACS Plot; CO
Referencing offset: 0.76 ppm, Outliers: 3 Detail
Protein Blocks Logo
Calculated from 25 models in PDB: 4CRP, Strand ID: A Detail


Release date
2015-01-11
Citation
GDNF, NGF and BDNF as therapeutic options for neurodegeneration
Allen, S.J., Watson, J.J., Shoemark, D.K., Barua, N.U., Patel, N.K.
Pharmacol. Ther. (2013), 138, 155-175, PubMed 23348013 , DOI 10.1016/j.pharmthera.2013.01.004 ,
Related entities 1. Solution structure of a TrkAIg2 domain construct for use in drug discovery, : 1 : 2 : 63 entities Detail
Interaction partners 1. Solution structure of a TrkAIg2 domain construct for use in drug discovery, : 14 interactors Detail
Experiments performed 7 experiments Detail
NMR combined restraints 3 contents Detail
Keywords Alzheimers, drug discovery, NMR construct, pain, TRANSFERASE, TrkA, TrkAIg2